Top Markets
Coin of the day
Celltrion Healthcare Co., Ltd. Celltrion Healthcare Co., Ltd.

Celltrion Healthcare Co., Ltd.

091990
Rank in Stocks #2264
Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on... Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on the development, manufacturing, and distribution of biosimilar and biological therapeutic agents for patients around the globe. Its product lineup includes Remsima, a monoclonal antibody biosimilar used to treat various inflammatory and autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, Crohn's disease in both adults and children, psoriasis, and psoriatic arthritis. Another significant offering, Truxima, targets conditions like lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, microscopic polyangiitis, and rheumatoid arthritis. Herzuma is prescribed for metastatic breast cancer, early-stage breast cancer, and metastatic gastric cancer. Additionally, Remsima SC provides a treatment option for rheumatoid arthritis. Founded in 1999, the enterprise was initially known as Nexol, Inc. before rebranding to Celltrion Healthcare Co., Ltd. in March 2009. The firm's corporate headquarters are situated in Incheon, South Korea.
Share Price
$57.75
Last synced: 2024-01-11
Market Cap
$9.42B
Change (1 day)
-0.25%
Change (1 year)
0.00%
Country
KR
Trade Celltrion Healthcare Co., Ltd. (091990)

Category

Stock split history for Celltrion Healthcare Co., Ltd. (091990)
Celltrion Healthcare Co., Ltd. stock (symbol: 091990) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 25, 2026.
One 091990 share bought prior to Aug 25, 2026 would equal to 0 091990 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH